Galderma

Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 33 wholly-owned affiliates with a worldwide network of distributors and approximately 5,500 employees. Galderma’s extensive product portfolio is available in 80 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.

Strategic brands include Epiduo®, Oracea®, Clobex®, Differin®, Mirvaso®, Rozex®/MetroGel®, Silkis®/Vectical®, Tri-Luma®, Loceryl®, Cetaphil®, Metvix®, Azzalure®, Restylane® and Emervel®.

Galderma headquartered in Switzerland, Europe, operates in the Health Care, Medical sector. With a team of 10001+ employees, Galderma is actively contributing to advancements in Health Care. Their latest funding round, Secondary Market - Galderma, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.